Novo Nordisk said on Friday a late-stage trial with a high-dose version of its weight loss drug semaglutide helped overweight ...
By coincidence (they started before GLP -1 drugs were approved for slimming), a group of 56 doctors have just answered that ...
Body Mass Index, or BMI, has long been criticized as an unreliable method for measuring obesity — and now a group of experts ...
A global group of experts has suggested a new approach to diagnosing and treating obesity that does not rely solely on the much-contested body mass index (BMI).
Our reframing acknowledges the nuanced reality of obesity and allows for personalized care,” said Dr. Francesco Rubino of ...
A new report says only using BMI to determine if a patient has obesity leads to under-diagnosing people who are ill and ...
The Centers for Medicare and Medicaid Services (CMS) identified 15 drugs it has selected for price negotiations with drug ...
When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...